Research News and Research

RSS

Cedars-Sinai researchers awarded $1.47M grant to study stem cell immune rejection response

A team of Cedars-Sinai Regenerative Medicine Institute researchers led by Terrence Town, Ph.D. has been awarded a three-year, $1.47 million grant from the California Institute for Regenerative Medicine to fund research into mechanisms for how human immune systems reject or accept transplanted brain stem cells.

24 Jun 2010

Today's OpEds: Extending jobless benefits; Medicare payment cuts; NY Times on premium increases

With critics still scare-mongering about the supposed cost of reform, insurers in several states have been seeking double-digit premium increases that look hard to justify as necessary to keep up with medical inflation.

24 Jun 2010

GOP continues attacks on health law, Boehner issues critical report

"Employers could lose their ability to change health plans or negotiate better rates and benefits under new healthcare reform regulations, the top GOP staffer on the Ways and Means Committee's health panel said Wednesday. Dan Elling, the Republican staff director for the health subcommittee, raised the issue during a CQ-Roll Call policy forum."

24 Jun 2010

CPRIT grants $3.7M to Rice University researchers to fund cancer diagnostics program

The Cancer Prevention and Research Institute of Texas has granted $3.7 million to Rice University researchers to fund an innovative cancer diagnostics program.

24 Jun 2010

Hidden heart condition raise stroke and heart failure risk: Report

According to the National Stroke Foundation a hidden and largely undetected heart condition is costing the Australian economy over $1.2 billion a year. In a report released today the Foundation has said that Atrial Fibrillation (AF), commonly manifested as severe irregularity of heart beat and palpitation that may go unnoticed is affecting more than 240,000 Australians at present with half over the age of 75.

23 Jun 2010

Female biology screens for the best sperm: Study

A new study has revealed that the female reproductive system is ‘choosy’ when it comes to inferior quality sperm and rejects the ‘advances’ of spermatozoa that are not good enough to create a pregnancy.

23 Jun 2010

How new health insurance regulations could affect some premiums, coverage

Kaiser Health News staff writer Phil Galewitz reports: "As he trumpeted what he called a new 'Patient's Bill of Rights' Tuesday, President Barack Obama tried to calm fears that the new health law would increase insurance costs.

23 Jun 2010

Several hospitals seek buyers or mergers to strengthen their bottom lines

The Boston Globe: Massachusetts officials are holding public comment sessions on a proposed sale of chain of hospitals in the state, and "scores of local officials, state representatives, community leaders, and employees and retirees of Caritas hospitals in Eastern Massachusetts have paraded to the podium to praise Caritas management and the private equity firm, Cerberus Capital Management, that has pledged to preserve the chain of six hospitals, at least for three years."

23 Jun 2010

Anthera commences enrollment in pivotal VISTA-16 Phase 3 clinical study of varespladib

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced patient enrollment has commenced in the Company's pivotal VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks) Phase 3 clinical study of varespladib (A-002).

23 Jun 2010

Democrats stymied on Medicare physician pay 'fix'

CongressDaily: "Medicare physician payments, unemployment benefits, aid to states and long-stalled tax breaks were all still in limbo Tuesday with no clear path forward." House Democrats are waiting for the Senate to act on the larger bill before considering a separate "doc fix" bill the Senate passed last week.

23 Jun 2010

NaturalNano nanotubes improve targeting of circulating tumor cells: Study

NaturalNano, Inc. announced today that Dr. Michael King, a researcher at Cornell University, has published a new study demonstrating how NaturalNano nanotubes can improve targeting of circulating tumor cells (CTC's). These nanotubes, when added to the surface where cancer cells are attracted, enhance the natural rolling mechanism that Dr. King believes will allow them to be exposed to specific drugs or other therapeutic agents, or isolated for diagnostic and research purposes.

23 Jun 2010

BioDigital, NYU Langone partner to create Right Upper Lobe Resection Cognitive Task Trainer

SensAble Technologies, a leader in haptic devices and 3D modeling solutions, announced that its customer, BioDigital, working in partnership with surgeons at NYU Langone Medical Center, has created the first medical simulation application for teaching residents the high-technology procedure for lung resection of the right upper lobe, most commonly performed to treat resectable lung cancers.

23 Jun 2010

University of Colorado honors Taligen as Bioscience Company of the Year

Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has been selected as the Bioscience Company of the Year by the University of Colorado with its 7th Annual Technology Transfer Awards in recognition of its leadership position in developing a pipeline of novel protein therapeutics that modulate the complement system to treat a wide range of inflammatory diseases.

23 Jun 2010

SIGA completes fourth human clinical trial of ST-246 smallpox antiviral drug candidate

SIGA Technologies, Inc., a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today the successful completion of its fourth human clinical trial, supporting the safety and tolerability of the anticipated clinical dose of ST-246®, SIGA's lead smallpox antiviral drug candidate.

23 Jun 2010

Window World selected to receive New Corporate Partner of the Year award

Window World, the nation's largest replacement window company, has been selected by St. Jude Children's Research Hospital to receive the hospital's celebrated "New Corporate Partner of the Year" award, given out annually to a new partner who demonstrates excellence and dedication in fundraising. A St. Jude corporate partner since 2008, Window World has raised more than $1 million for the hospital, which is one of the world's premier centers for the research and treatment of pediatric cancer and other catastrophic childhood diseases.

23 Jun 2010

BASF signs agreement to acquire Cognis for equity purchase price of euro 700 million

BASF SE has reached an agreement with Cognis Holding Luxembourg S.a r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences to acquire the specialty chemicals company Cognis for an equity purchase price of euro 700 million. Including net financial debt and pension obligations, the enterprise value of the transaction is euro 3.1 billion. The acquisition is subject to clearance by the competent merger control authorities. Closing of the transaction is expected for November 2010 at the latest.

23 Jun 2010

New research project to review accuracy of medical diagnoses

A new research project at the University of Leicester will review the accuracy of medical diagnoses. Evaluating diagnostic strategy is crucial to clinical practice as it helps maximise the efficacy of the treatments which are offered to patients. Many lives are affected every day by the diagnoses made by hospitals and medical doctors, and it is vital that diagnoses are accurate.

23 Jun 2010

Shift in balance between good and bad bacteria in gut could be a harbinger of colon cancer: Study

The human body contains more bacteria than it does cells. These bacterial communities can have a positive effect on our health, by training our immune systems and helping to metabolize the foods we eat. But they can also set us up to develop digestive disorders, skin diseases, and obesity.

23 Jun 2010

MAP Pharmaceuticals to present new analyses on LEVADEX from FREEDOM-301 Phase 3 clinical trial

MAP Pharmaceuticals, Inc. announced today it will present new analyses from the FREEDOM-301 Phase 3 clinical trial in a late breaker session at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California on Friday, June 25 from 3:30 to 4:00 pm PT. The presentation will show that the Company's investigational LEVADEX™ orally inhaled migraine therapy was effective irrespective of when it was administered during a migraine cycle.

23 Jun 2010

Company took measures to protect employees from H1N1 flu: National poll

In response to the H1N1 flu, most employees at U.S. businesses say their company took measures to protect them from illness, such as encouraging sick employees to stay home, according to a national poll of employees by researchers from the Harvard Opinion Research Program at Harvard School of Public Health.

23 Jun 2010

Research News and Research

Cedars-Sinai researchers awarded $1.47M grant to study stem cell immune rejection response

Today's OpEds: Extending jobless benefits; Medicare payment cuts; NY Times on premium increases

GOP continues attacks on health law, Boehner issues critical report

CPRIT grants $3.7M to Rice University researchers to fund cancer diagnostics program

Hidden heart condition raise stroke and heart failure risk: Report

Female biology screens for the best sperm: Study

How new health insurance regulations could affect some premiums, coverage

Several hospitals seek buyers or mergers to strengthen their bottom lines

Anthera commences enrollment in pivotal VISTA-16 Phase 3 clinical study of varespladib

Democrats stymied on Medicare physician pay 'fix'

NaturalNano nanotubes improve targeting of circulating tumor cells: Study

BioDigital, NYU Langone partner to create Right Upper Lobe Resection Cognitive Task Trainer

University of Colorado honors Taligen as Bioscience Company of the Year

SIGA completes fourth human clinical trial of ST-246 smallpox antiviral drug candidate

Window World selected to receive New Corporate Partner of the Year award

BASF signs agreement to acquire Cognis for equity purchase price of euro 700 million

New research project to review accuracy of medical diagnoses

Shift in balance between good and bad bacteria in gut could be a harbinger of colon cancer: Study

MAP Pharmaceuticals to present new analyses on LEVADEX from FREEDOM-301 Phase 3 clinical trial

Company took measures to protect employees from H1N1 flu: National poll

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence